Dr. Mortensen received his doctorate in immunology and vaccinology at University of Copenhagen and is Head of TB Vaccine Research at Statens Serum Institut in Copenhagen, Denmark. His responsibilities cover development activities from early discovery and vaccine design to testing and transitioning into clinical trials. His group is studying protective immunological mechanisms of vaccine mediated immunity with a specific focus on Th1/Th17 cells and utilize the knowledge gathered in clinical trails and animal experiments to generate better next-generation TB vaccines.